Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-28
DOI
10.3389/fnins.2017.00432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Antipsychotic Use and Major Cardiovascular Events
- (2017) Alejandro G. Szmulewicz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis
- (2017) Karsten G. Jensen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis
- (2017) Błażej Misiak et al. SCHIZOPHRENIA RESEARCH
- Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study
- (2017) Adrian Heald et al. Annals of General Psychiatry
- Impaired Glucose Homeostasis in First-Episode Schizophrenia
- (2017) Toby Pillinger et al. JAMA Psychiatry
- Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia
- (2017) M S Mostaid et al. Translational Psychiatry
- Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes
- (2017) Jiang Li et al. SCHIZOPHRENIA RESEARCH
- Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice
- (2017) Takatomo Arai et al. Scientific Reports
- Neuregulin improves response to glucose tolerance test in control and diabetic rats
- (2016) Iliana López-Soldado et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Neuregulin 1 improves glucose tolerance in adult and old rats
- (2016) K. Caillaud et al. DIABETES & METABOLISM
- A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population
- (2016) Jeffrey Rado et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH
- (2016) Erica J P Anderson et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The atypical antipsychotic, olanzapine, potentiates ghrelin-induced receptor signaling: An in vitro study with cells expressing cloned human growth hormone secretagogue receptor
- (2016) Keita Tagami et al. NEUROPEPTIDES
- The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms
- (2016) Dominic Landgraf et al. NEUROPHARMACOLOGY
- Histamine and the striatum
- (2016) J. Paul Bolam et al. NEUROPHARMACOLOGY
- Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain
- (2016) Clement C. Zai et al. NEUROPSYCHOBIOLOGY
- Dopaminergic drugs in type 2 diabetes and glucose homeostasis
- (2016) Felicitas Lopez Vicchi et al. PHARMACOLOGICAL RESEARCH
- Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
- (2016) Zachary J. Farino et al. PLoS One
- Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits
- (2016) D. C. Chen et al. PSYCHOLOGICAL MEDICINE
- Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study
- (2016) María José Morlán-Coarasa et al. PSYCHOPHARMACOLOGY
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
- (2016) Jian-Ping Zhang et al. SCHIZOPHRENIA BULLETIN
- Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain
- (2016) Arun K. Tiwari et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
- (2016) E.M. Lamos et al. Primary Care Diabetes
- Alpha-Melanocyte-Stimulating Hormone and Agouti-Related Protein: Do They Play a Role in Appetite Regulation in Childhood Obesity?
- (2016) Aysel Vehapoğlu et al. Journal of Clinical Research in Pediatric Endocrinology
- Pro-Opiomelanocortin (POMC) Neurones, POMC-Derived Peptides, Melanocortin Receptors and Obesity: How Understanding of this System has Changed Over the Last Decade
- (2015) K. G. Mountjoy JOURNAL OF NEUROENDOCRINOLOGY
- Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia
- (2015) Ahmed Naguy et al. NORDIC JOURNAL OF PSYCHIATRY
- Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways
- (2015) Jiamei Lian et al. PHARMACOLOGICAL RESEARCH
- Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
- (2015) Shi Hyun Kang et al. Psychiatry Investigation
- Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: Evidence for insulin resistance
- (2015) Petros Petrikis et al. PSYCHIATRY RESEARCH
- Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
- (2015) Francesco Bartoli et al. PSYCHONEUROENDOCRINOLOGY
- Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings
- (2015) Aslı Enez Darcin et al. SCHIZOPHRENIA RESEARCH
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders
- (2015) Rita Barandas et al. Current Psychiatry Reports
- Association between MC4R rs17782313 polymorphism and overeating behaviors
- (2014) Z Yilmaz et al. INTERNATIONAL JOURNAL OF OBESITY
- Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
- (2014) Lin Mei et al. NEURON
- Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action
- (2014) Hao Tang et al. PHARMACOGENOMICS
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Circadian Clock and Stress Interactions in the Molecular Biology of Psychiatric Disorders
- (2014) Dominic Landgraf et al. Current Psychiatry Reports
- Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
- (2014) Tahireh A. Shams et al. Current Psychiatry Reports
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
- (2013) L. Fredrik Jarskog et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate Mediates the Function of Melanocortin Receptor 4 on Sim1 Neurons in Body Weight Regulation
- (2013) Yuanzhong Xu et al. Cell Metabolism
- The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain
- (2013) Meng He et al. CNS DRUGS
- Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
- (2013) Chao Deng ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Modelling olanzapine-induced weight gain in rats
- (2013) E. M. van der Zwaal et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Polymorphisms of the Histamine Receptor (H1HR) Gene Are Not Associated With Olanzapine-Induced Weight Gain
- (2013) Beata R. Godlewska et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Weight Gain in Risperidone Therapy
- (2013) Tulin Yanik et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms
- (2013) Shaodong Guo JOURNAL OF ENDOCRINOLOGY
- Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight
- (2013) Xueqin Song et al. SCHIZOPHRENIA RESEARCH
- 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
- (2013) Michael D. Gershon Current Opinion in Endocrinology Diabetes and Obesity
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- Life expectancy and cardiovascular mortality in persons with schizophrenia
- (2012) Thomas M. Laursen et al. CURRENT OPINION IN PSYCHIATRY
- Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
- (2012) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor
- (2012) Amy Hauck Newman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dopamine-Mediated Autocrine Inhibitory Circuit Regulating Human Insulin Secretionin Vitro
- (2012) Norman Simpson et al. MOLECULAR ENDOCRINOLOGY
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
- (2012) A. J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- The rise and fall of the atypical antipsychotics
- (2011) Tim Kendall BRITISH JOURNAL OF PSYCHIATRY
- Bromocriptine for Diabetes Mellitus Type II
- (2011) Guy Valiquette Cardiology in Review
- Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder
- (2011) Leslie Citrome et al. CLINICAL DRUG INVESTIGATION
- Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
- (2011) Maria J. Arranz et al. CNS DRUGS
- The METEOR study
- (2011) Bruno Falissard et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature
- (2011) E M van der Zwaal et al. INTERNATIONAL JOURNAL OF OBESITY
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Dopamine Receptors in Human Adipocytes: Expression and Functions
- (2011) Dana C. Borcherding et al. PLoS One
- Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor
- (2011) E. Gonzalez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quick-Release Bromocriptine for Treatment of Type 2 Diabetes
- (2011) Nasser Mikhail Current Drug Delivery
- Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats
- (2010) Katrina Weston-Green et al. BEHAVIOURAL BRAIN RESEARCH
- Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome
- (2010) Anamika Banerjee et al. BRAIN RESEARCH BULLETIN
- Bromocriptine: old drug, new formulation and new indication
- (2010) R. I. G. Holt et al. DIABETES OBESITY & METABOLISM
- Minireview: New Roles for Peripheral Dopamine on Metabolic Control and Tumor Growth: Let’s Seek the Balance
- (2010) Blanca Rubí et al. ENDOCRINOLOGY
- Orally Disintegrating and Oral Standard Olanzapine Tablets Similarly Elevate the Homeostasis Model Assessment of Insulin Resistance Index and Plasma Triglyceride Levels in 12 Healthy Men
- (2010) Solrun Vidarsdottir et al. JOURNAL OF CLINICAL PSYCHIATRY
- Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
- (2010) MRA Muscatello et al. JOURNAL OF PSYCHOPHARMACOLOGY
- New Insights into the Endocrine and Metabolic Roles of Dopamine D2 Receptors Gained from the Drd2–/– Mouse
- (2010) Isabel Garcia-Tornadú et al. NEUROENDOCRINOLOGY
- Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
- (2010) Robert J. Fountaine et al. Obesity
- Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial
- (2010) Preeta Kaur Narula et al. SCHIZOPHRENIA RESEARCH
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
- (2010) Caline S. Karam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia
- (2009) D. C. Henderson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Emerging role of neuregulin as a modulator of muscle metabolism
- (2009) Anna Gumà et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
- (2009) Emilio Fernandez-Egea et al. BRITISH JOURNAL OF PSYCHIATRY
- A Review of Sensitivity and Tolerability of Antipsychotics in Patients With Bipolar Disorder or Schizophrenia
- (2009) Keming Gao et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Polymorphisms of Serotonin Receptor 2A and 2C Genes and COMT in Relation to Obesity and Type 2 Diabetes
- (2009) Sofia I. I. Kring et al. PLoS One
- Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study
- (2009) Ya Mei Bai et al. SCHIZOPHRENIA RESEARCH
- Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension
- (2008) M. Baltatzi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
- (2007) Dawn L. Thiselton et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started